The European Medicines Watchdog EMA is positive for an antibody, discovered by researchers at the UMC in Amsterdam, which is supposed to protect newborns from the life-threatening RS virus.
–
As soon as the European Commission approves the drug called Nirsevimab, it can be used against respiratory syncytial virus.
Each year, 150 to 200 children end up in intensive care with the cold virus, says the UMC in Amsterdam. Children’s intensive care professor Job van Woensel of the UMC in Amsterdam says the drug is expected to prevent much suffering and death around the world. Hardly any children die here from the virus. (ANP)
<!–
–>
–
